Department of Defense
DIRECTIVE
NUMBER 6025.21E
July 5, 2006
USD(AT&L)
SUBJECT: Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries
References: (a) Section 256 of Public Law 109-163, “National Defense Authorization Act for
Fiscal Year 2006”
1
(b) DoD Directive 5101.1, “DoD Executive Agent,” September 3, 2002
(c) DoD Directive 5134.3, “Director of Defense Research and Engineering
(DDR&E),”November 3, 2003
(d) DoD Directive 5025.1, “DoD Directives System,” March 2005
(e) through (g), see Enclosure 1
1.
PURPOSE
This Directive:
1.1. Implements Reference (a) by establishing policy and assigning responsibilities
governing coordination and management of medical research efforts and DoD programs related
to prevention, mitigation, and treatment of blast injuries.
1.2. Designates the Secretary of the Army, in compliance with Reference (a) and consistent
with Reference (b), as the DoD Executive Agent (DoD EA) for Medical Research for Prevention,
Mitigation, and Treatment of Blast Injuries according to Reference (b).
1.3. Establishes the Armed Services Biomedical Research Evaluation and Management
(ASBREM) Committee. The ASBREM Committee serves to facilitate coordination and prevent
unnecessary duplication of effort within DoD biomedical research and development and
associated enabling research areas, to include serving as the forum for implementation of
subsections (d) and (g) of Reference (a).
1
Federal legislative information is available through the Library of Congress THOMAS site, http://thomas.loc.gov.
